Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Kyndryl Holdings Inc (KD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs Kyndryl Holdings Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.78 (market cap $4.03B), while Kyndryl Holdings Inc trades at $12.47 (market cap $2.57B). The key difference: Indivior Pharmaceuticals Inc. Common Stock is the larger of the two by market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, Kyndryl Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Kyndryl Holdings Inc for 36 Days on average.
| INDV | KD | |
|---|---|---|
Market Cap | $4.03B | $2.57B |
Volume | 2,781,171 | 3,294,342 |
Sector | Health | Technology |
52-Week High | $41.83 | $28.92 |
52-Week Low | $24.09 | $10.59 |
Typical Hold Time | 0 Days | 36 Days |
Enterprise Value | $4.32B | $5.39B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kyndryl (KD) trades at $12.24, up 3.9% on the day, with a neutral technical signal and bearish moving averages. The company reported a return to profitability in 2025 with net income of $252 million, though revenue has declined from prior years. Recent news highlights a strategic focus on AI, including the launch of an innovation lab and an acquisition to bolster healthcare IT services. Positive cash flow generation and a low EV/EBITDA of 3.8 suggest underlying value, but consecutive earnings misses and a high P/E ratio of 31.9 present challenges.
The investment outlook is mixed. A consensus price target of $14.67 implies potential upside, supported by strong operational cash flow and debt reduction. However, risks include declining revenue, thin net margins, and a majority 'Hold' analyst rating. The stock's performance hinges on successful execution of its AI strategy and reversing the top-line contraction seen in recent years.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About Kyndryl Holdings Inc
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →
